Champions Oncology (CSBR) Total Non-Current Liabilities (2011 - 2026)

Champions Oncology (CSBR) has 16 years of Total Non-Current Liabilities data on file, last reported at $28.6 million in Q3 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 6.21% year-over-year to $28.6 million in Q3 2026; TTM through Jul 2026 was $28.6 million, a 6.21% increase from a year earlier, with the FY2026 full-year figure at $22.9 million, down 19.56% from the prior year.
• Total Non-Current Liabilities for Q3 2026 stood at $28.6 million, up from $22.9 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $29.1 million in Q2 2023 and bottomed at $22.9 million in Q2 2026.
• Historically, Total Non-Current Liabilities has averaged $26.4 million across 5 years, with a median of $26.6 million in 2022.
• The widest annual swing landed in 2022, when Total Non-Current Liabilities jumped 41.92%; it then decreased 19.56% in 2026.
• Year by year, Total Non-Current Liabilities stood at $26.6 million in 2022, then rose by 4.35% to $27.7 million in 2023, then dropped by 12.59% to $24.2 million in 2024, then grew by 6.81% to $25.9 million in 2025, then advanced by 10.55% to $28.6 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $28.6 million in Q3 2026, $22.9 million in Q2 2026, and $24.0 million in Q1 2026.